Huey-Fen Chen

Ms. Huey-Fen Chen


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Vaccine
Verified
Journal Article
Closed access
KMKristin A. Maurer
Kristin A. Maurer
HCHuey-Fen Chen
Huey-Fen Chen
AWAbram Wagner
Abram Wagner
SHSonia T. Hegde
Sonia T. Hegde
TPTejasi Patel
Tejasi Patel
DHDavid W. Hutton
David W. Hutton

12 May 2021 in Children
Verified
Journal Article
Open access
PDF file
HCHuey-Fen Chen
Huey-Fen Chen
ARAngela M. Rose
Angela M. Rose
SWSusan Waisbren
Susan Waisbren
AAAyesha Ahmad
Ayesha Ahmad
LPLisa Prosser
Lisa Prosser
The objective of this study was to evaluate the cost-effectiveness of newborn screening and treatment for phenylketonuria (PKU) in the context of new data on adherence to recommended diet treatment and a newly available drug treatment (sapropterin dihydrochloride). A computer simulation model was developed to project outcomes for a hypothetical cohort of newborns with PKU. Four strategies were compared: (1) clinical identification (CI) with diet treatment; (2) newborn screening (NBS) with diet treatment; (3) CI with diet and medication (sapropterin dihydrochloride); and (4) NBS with diet and medication. Data sources included published literature, primary data, and expert opinion. From a societal perspective, newborn screening with diet treatment had an incremental cost-effectiveness ratio of $6400/QALY compared to clinical identification with diet treatment. Adding medication to NBS with diet treatment resulted in an incremental cost-effectiveness ratio of more than $16,000,000/QALY. Uncertainty analyses did not substantially alter the cost-effectiveness results. Newborn screening for PKU with diet treatment yields a cost-effectiveness ratio lower than many other recommended childhood prevention programs even if adherence is lower than previously assumed. Adding medication yields cost-effectiveness results unlikely to be considered favorable. Future research should consider conditions under which sapropterin dihydrochloride would be more economically attractive.